Food and Drug Administration Commissioner Marty Makary is on “thin ice” with the White House, according to two sources familiar with discussions.
Makary, a surgical oncologist who first gained prominence critiquing the government’s handling of the COVID-19 pandemic, has been on shaky ground both inside the agency and with the White House for months.
He was the subject of a scathing Bloomberg report this week, which said his tenure has been marked by friction among staff and leadership, industry frustration and a general dysfunction in the agency responsible for regulating the nation’s pharmaceutical supply and approving new drugs.